Key result
Serum total cholesterol levels did not significantly differ between patients who died by suicide and matched non-suicide controls across schizophrenia, bipolar affective disorder, and major depressive disorder groups.
Why the study?
Do serum lipid levels predict death by suicide in patients with schizophrenia, bipolar affective disorder, or major depressive disorder?
Case-Control (n=516)
No
Do serum lipid levels predict death by suicide in patients with schizophrenia, bipolar affective disorder, or major depressive disorder?
Serum total cholesterol is not a useful biological indicator to predict suicide risk among patients with major psychiatric disorders.
Serum cholesterol should not guide suicide risk assessment in severe mental illness; Level 4 data leave predictive value open for prospective study.
BACKGROUND: Previous research on serum total cholesterol and suicidality has yielded conflicting results. Several studies have reported a link between low serum total cholesterol and suicidality, whereas others have failed to replicate these findings, particularly in patients with major affective disorders. These discordant findings may reflect the fact that studies often do not distinguish between patients with bipolar and unipolar depression; moreover, definitions and classification schemes for suicide attempts in the literature vary widely. METHODS: Subjects were patients with one of the three major psychiatric disorders commonly associated with suicide: schizophrenia, bipolar affective disorder, and major depressive disorder (MDD). We compared serum lipid levels in patients who died by suicide (82 schizophrenia, 23 bipolar affective disorder, and 67 MDD) and non-suicide controls (200 schizophrenia, 49 bipolar affective disorder, and 175 MDD). RESULTS: Serum lipid profiles did not differ between patients who died by suicide and control patients in any diagnostic group. CONCLUSIONS: Our results do not support the use of biological indicators such as serum total cholesterol to predict suicide risk among patients with a major psychiatric disorder.
No takes yet. Share an insight, caveat, or question.
Park et al. (2013) conducted a case-control in Schizophrenia, bipolar affective disorder, or major depressive disorder (n=516). Serum total cholesterol vs. Non-suicide controls was evaluated on Serum total cholesterol levels. Serum total cholesterol levels did not significantly differ between patients who died by suicide and matched non-suicide controls across schizophrenia, bipolar affective disorder, and major depressive disorder groups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: